artículo académico

• Corrigendum: Genetic and Phenotypic Characterization of the Etiological Agent of Canine Orchiepididymitis Smooth Brucella sp. BCCN84.3.  Frontiers in Veterinary Science.  6. 2019
• Genetic and Phenotypic Characterization of the Etiological Agent of Canine Orchiepididymitis Smooth Brucella sp. BCCN84.3.  Frontiers in Veterinary Science.  6:1-6. 2019
• Identification of lptA, lpxE, and lpxO, Three Genes Involved in the Remodeling of Brucella Cell Envelope.  Frontiers in Microbiology.  8. 2018
• Immunomodulatory properties of Brucella melitensis lipopolysaccharide determinants on mouse dendritic cells in vitro and in vivo.  Virulence.  9:465-479. 2017
• Vaccine development targeting lipopolysaccharide structure modification.  Jiménez Osornio, Juan.  20:455-460. 2017
• Structural Studies of Lipopolysaccharide Defective Mutants from Brucella melitensis Identify a Core Oligosaccharide Critical in Virulence.  Journal of Biological Chemistry.  291:7727-7741. 2016
• The identification of wadB, a new glycosyltransferase gene, confirms the branched structure and the role in virulence of the lipopolysaccharide core of Brucella abortus.  Microbial Pathogenesis.  73:53-59. 2014
• Lipopolysaccharide as a target for brucellosis vaccine design.  Microbial Pathogenesis.  58:29-34. 2013
• Brucella β 1,2 Cyclic Glucan Is an Activator of Human and Mouse Dendritic Cells.  PLos Pathogens.  8:e1002983. 2012
• The Lipopolysaccharide Core of Brucella abortus Acts as a Shield Against Innate Immunity Recognition.  PLos Pathogens.  8:e1002675. 2012
• What have we learned from brucellosis in the mouse model?.  BMC Veterinary Research.  43:29. 2012
• Brucella abortus Ornithine Lipids Are Dispensable Outer Membrane Components Devoid of a Marked Pathogen-Associated Molecular Pattern.  PLoS ONE.  6:e16030. 2011
• Docencia universitaria en pregrado en ciencias de la salud.  BMC Genomics.  11:300. 2010
• Is Brucella an enteric pathogen?.  Nature Reviews Microbiology.  7:250. 2009
• The Differential Interaction of Brucella and Ochrobactrum with Innate Immunity Reveals Traits Related to the Evolution of Stealthy Pathogens.  PLoS ONE.  4:e5893. 2009
• Brucellosis Vaccines: Assessment of Brucella melitensis Lipopolysaccharide Rough Mutants Defective in Core and O-Polysaccharide Synthesis and Export.  PLoS ONE.  3:e2760. 2008
• Brucella abortus Uses a Stealthy Strategy to Avoid Activation of the Innate Immune System during the Onset of Infection.  PLoS ONE.  2:e631. 2007
• BvrR/BvrS-Controlled Outer Membrane Proteins Omp3a and Omp3b Are Not Essential for Brucella abortus Virulence.  Infection and Immunity.  75:4867-4874. 2007
• Regulation of Brucella virulence by the two-component system BvrR/BvrS.  Veterinary Microbiology.  90:329-339. 2002
• The two-component system BvrR/BvrS essential for Brucella abortus virulence regulates the expression of outer membrane proteins with counterparts in members of the Rhizobiaceae.  Proceedings of the National Academy of Sciences.  99:12375-12380. 2002